Back to Trades
Prime Medicine, Inc.
PRMECIK: 0001894562
Follow PRME
Track Prime Medicine, Inc. insider trades on your dashboard. Email alerts with a subscription.
Prime Medicine, Inc. (PRME) has recorded 25 insider filings from 13 unique insiders, totaling $73.5M in trading activity (net buying). Insiders have purchased $30.0M and sold $0, reflecting a net buying posture that may signal internal confidence in the company's near-term prospects. The most active insider by volume is Reine Allan. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.
Total Volume
$73.5M
Purchases
$30.0M
Sales
$0
Unique Insiders
13
Recent Insider Trades
25 loaded
| Jun 8 | PRME Prime Medicine, Inc. | Marrazzo Jeffrey D | Director | Other | $0 |
| Jun 8 | PRME Prime Medicine, Inc. | Cahill Thomas | Director | Other | $0 |
| Jun 8 | PRME Prime Medicine, Inc. | Foster-Cheek Kaye I | Director | Other | $0 |
| Jun 8 | PRME Prime Medicine, Inc. | Chung Wendy | Director | Other | $0 |
| Jun 8 | PRME Prime Medicine, Inc. | Schenkein David P | Director | Other | $0 |
| Jun 8 | PRME Prime Medicine, Inc. | Kelly Michael Aaron | Director | Other | $0 |
| Jun 8 | PRME Prime Medicine, Inc. | NELSEN ROBERT | Director, 10% Owner | Other | $0 |
| Apr 17 | PRME Prime Medicine, Inc. | Makhni Svetlana Ni | Chief Financial Officer | Other | $0 |
| Apr 17 | PRME Prime Medicine, Inc. | Makhni Svetlana Ni | Chief Financial Officer | Other | $0 |
| Feb 27 | PRME Prime Medicine, Inc. | Reine Allan | Chief Executive Officer, Director | Other | $0 |
| Feb 24 | PRME Prime Medicine, Inc. | Alenson Carman | See Remarks | Other | $0 |
| Feb 24 | PRME Prime Medicine, Inc. | LEE ANN L. | Chief Technical Officer | Other | $0 |
| Aug 1 | PRME Prime Medicine, Inc. | ARCH Venture Partners X, LLC | 10% Owner | Buy | $10.0M |
| Aug 5 | PRME Prime Medicine, Inc. | Reine Allan | Chief Executive Officer, Director | Other | $0 |
| Aug 5 | PRME Prime Medicine, Inc. | Kelly Michael Aaron | Director | Other | $0 |
| Aug 5 | PRME Prime Medicine, Inc. | Marrazzo Jeffrey D | Director | Other | $0 |
| Aug 5 | PRME Prime Medicine, Inc. | Alenson Carman | See Remarks | Other | $0 |
| Aug 1 | PRME Prime Medicine, Inc. | NELSEN ROBERT | Director, 10% Owner | Buy | $10.0M |
| Aug 5 | PRME Prime Medicine, Inc. | Schenkein David P | Director | Other | $0 |
| Aug 5 | PRME Prime Medicine, Inc. | Chung Wendy | Director | Other | $0 |
| Aug 5 | PRME Prime Medicine, Inc. | Foster-Cheek Kaye I | Director | Other | $0 |
| Aug 5 | PRME Prime Medicine, Inc. | LEE ANN L. | Chief Technical Officer | Other | $0 |
| Aug 5 | PRME Prime Medicine, Inc. | NELSEN ROBERT | Director, 10% Owner | Other | $0 |
| Aug 5 | PRME Prime Medicine, Inc. | Cahill Thomas | Director | Other | $0 |
| Aug 1 | PRME Prime Medicine, Inc. | ARCH Venture Partners XII, LLC | 10% Owner | Buy | $10.0M |
25 filings